DFE Pharma appoints Peter Rose as new Chief Operating Officer
The appointment reinforces DFE Pharma’s commitment to reliable supply, scalable operations and continuous improvement.
Pharma
BioPhorum's Digital Technology Transfer Playbook
BioPhorum's Digital Technology Transfer Playbook lays out guiding principles for using digital tools, structured data, and digital product definitions to make technology transfer faster and more consistent.
Sponsored • News
The Smart Factory Begins in Engineering
Why digital continuity, shared data models, and integrated engineering shape plant performance before operations begin.
Sponsored • News
Predictive Decision Support for Pharmaceutical Manufacturing
INOSIM Foresight brings simulation into operations, boosting capacity, reliability, and smarter decisions.
Sponsored • News
Beyond Bottlenecks: A Simulation-Based Path to Higher Capacity
Using INOSIM Insight to reveal hidden bottlenecks, validate engineering decisions, and accelerate capacity expansion
Agilent Expands Oligonucleotide Manufacturing Capabilities With New Boulder Lab
Additional laboratory capacity supports development and scale-up of emerging oligonucleotide manufacturing technologies.
Hovione to Install Next-Gen Continuous Tableting System in the US
Investment to strengthen an integrated US pathway from amorphous solid dispersion via spray drying to tablet production at a single site, under one quality system.
Sterling Expands ADC Manufacturing Capacity and Capabilities
Sterling Pharma Solutions has announced completion of an additional, large-scale GMP manufacturing suite at its dedicated bioconjugation facility in the UK, which will double capacity.
Bayer to Invest $2.2 Billion in New US Pharma Manufacturing Site
Bayer will invest $2.2 billion in a new pharma manufacturing site in New Albany, Ohio. The modular plant covers drug substance and product manufacturing, opening in phases from 2031.
Bridging Speed and First-Time-Right Scale-Up
As pharma outsourcing grows, CDMOs must balance speed and quality across intermediates, KSMs, RSMs and APIs, while process gaps and technology transfer challenge First-Time-Right scale-up.
Nine Major European Pharma Companies Warn of Investment Decline in Joint Open Letter
The chairs of nine of Europe's largest pharmaceutical companies published a joint open letter warning that Europe's share of global pharmaceutical R&D has fallen.
CordenPharma Appoints Jean-Luc Herbeaux as Chief Executive Officer
Jean-Luc Herbeaux appointed Chief Executive Officer of CordenPharma, effective 1 October 2026. Michael Quirmbach to transition from President & CEO to Board Member and Senior Advisor.
From Scientific Excellence to Industrial Implementation
China’s Biopharmaceutical and Medtech Sector in 2026
Beyond Open Innovation: How to Make Pharma–Biotech Collab Work at Scale
Pharma is turning to open-innovation platforms like Bayer Co.Lab to speed science to clinic. CHEManager’s Christene Smith talks to Ruth Shah about the model and its value for start-ups and pharma.
Beyond Cost: What Manufacturers Look for in Investment Locations
Since COVID, pharma manufacturers have shifted from lean, centralized supply chains toward regionalized hubs — balancing cost, flexibility, and geopolitical security to build resilience against future economic shocks.
The Search Function: What AI Can't Replace in Biopharma Innovation
In AI-driven biopharma R&D, success means spotting outside innovation. CSL's Nishtha Jain on building AI platforms for external innovation, keeping human judgment central, and evolving leadership amid AI and ethics.
Lilly Breaks Ground on $6.5 Billion Houston Manufacturing Plant
Eli Lilly broke ground on a $6.5 billion Houston plant that will make Foundayo (orforglipron) and other medicines, creating over 600 jobs as part of its $50 billion push to reshore US drug manufacturing.
Prange Group Sells Remaining Shares in Adragos Pharma
German CDMO Prange has sold all remaining shares in Adragos Pharma to FSN Capital.
CDMOs/CMOs: The Key Moves in 2026
What have been key moves—capacity additions and acquisitions by CDMOs of drug substances (small molecules and biologics) thus far in 2026? A roundup of key developments.
Hovione Opens New Facility, Doubling US Spray Drying Capacity
Milestone completes a $100 million investment cycle in New Jersey and supports Hovione’s long-term vision for a next-generation pharmaceutical development and manufacturing hub.
Aseptic processing by design: The flexible and efficient use of RABS and Isolators
Explore how the flexible and efficient use of RABS and Isolators combined with operational expertise can address the challenges of aseptic processing.
PharmaBlock Inaugurates its New OPC R&D Center in Nanjing, China
PharmaBlock Sciences officially inaugurated its new OPC (Oligonucleotides, Peptides, and Conjugates) R&D Center in Nanjing, China.
DFE Pharma’s CM Platform accelerates the path from CM adoption to optimized performance
Navigate complex CM decisions with the right excipients, practical testing access and process understanding.
How Pharmaceutical Logistics Comes Together
Europe-wide 360° contract logistics for the pharmaceutical and healthcare industries are becoming even smoother—thanks to the new developments presented at CPHI in Milan.
CordenPharma Invests €80 Million to Expand Sterile Injectable Capacity
CordenPharma is investing €80 million at its Caponago, Italy, site, adding a new facility and fill-finish lines to lift sterile injectable capacity to 500 million units/year, backed by shareholder Astorg.
Lonza Announces Addition of Commercial Spray-Drying Facility at Bend Site
The investment will reinforce the Bend site as a center of excellence for particle engineering and bioavailability enhancement and create a global manufacturing hub for commercial spray-drying.
Clarity, Quality and Efficiency
Unveiled in April 2026, Brenntag's biopharma brand, Byphar, is aimed at companies in the biopharmaceutical industry. Joakim Rehné, President of Brenntag Pharma EMEA, explains the strategy behind the new brand.
Hovione Names Stefan Doboczky New CEO
Stefan Doboczky to take over operational leadership of the family-owned pharmaceutical technology and services group on April 1, 2027.
Northway Biotech Opens €61 Million Cell Therapy and Personalized Medicine CDMO
Northway Biotech is significantly expanding its development and manufacturing capacity with a new 3,500 sq. m facility featuring up to 20 independent cGMP manufacturing lines.
Beyond the Catalog: Enamine's Journey to Global Drug Discovery Partner
In 2026, Enamine celebrates 35 years — from a small grant-funded Kyiv lab to a global partner with 3,000+ people across six countries.
Samsung Biologics Launches CHF 1.46 Billion Tender Offer for PolyPeptide
Samsung Biologics has published its formal offer prospectus to acquire PolyPeptide, deepening its push into peptide manufacturing as CDMOs race to expand capacity for GLP-1 and other peptide-based drugs.
Evonik Invests €93 Million in Vancouver GMP Plant to Triple LNP Capacity
New GMP (Good Manufacturing Practice) facility to meet increasing demand for lipid nanoparticle (LNP) development and clinical drug product manufacturing.
Wiley Launches Its First Spectral Analysis API Portfolio
New APIs extend Wiley's gold-standard spectral data and analytical intelligence directly into lab, vendor, and platform workflows.
Hovione Completes €40 Million Expansion of Loures Tablet Manufacturing Center
Expansion strengthens integrated manufacture of amorphous solid dispersions (ASDs) by spray drying and tableting at a single site, accelerating development and simplifying supply.
